Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Moodys
Harvard Business School
Johnson and Johnson
Mallinckrodt

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Santarus Inc. v. Par Pharmaceutical Inc. (D. Del. 2007)

See Plans and Pricing

« Back to Dashboard

Santarus Inc. v. Par Pharmaceutical Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-09-13
Court District Court, D. Delaware Date Terminated 2014-09-29
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Plaintiff Referred To
Parties CURATORS OF THE UNIVERSITY OF MISSOURI; PAR PHARMACEUTICAL INC.; SANTARUS INC.
Patents 4,255,431; 4,508,905; 4,636,499; 4,738,974; 4,786,505; 4,853,230; 5,013,743; 5,045,321; 5,093,132; 5,093,342; 5,229,137; 5,599,794; 5,629,305; 5,690,960; 5,753,265; 5,817,338; 5,840,737; 5,972,389; 6,123,962; 6,143,771; 6,147,103; 6,150,380; 6,166,213; 6,248,363; 6,489,346; 6,645,988; 6,699,885; 6,780,882; 7,399,772; 9,040,039
Attorneys Aziz Burgy; Frederick L. Cottrell , III; Jack B. Blumenfeld; James Walter Parrett , Jr.; Janine A. Carlan; Steven J. Fineman; Timothy W. Bucknell
Link to Docket External link to docket
Small Molecule Drugs cited in Santarus Inc. v. Par Pharmaceutical Inc.
Biologic Drugs cited in Santarus Inc. v. Par Pharmaceutical Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Santarus Inc. v. Par Pharmaceutical Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-09-13 1 Complaint . 4,182,766 A 1/1980 Krasso et al. 4,255,431 A 3]1981 Junggren et al. 4,337,257 A 6/1982 funggren et ai… et af- CA 119 :278792, ooishi et al., 1993.* 4,255,431 A 3/1981 Junggren etal_ _ _ 4,337,257 A 6/1982…. 4,182,766 A 1f1980 Krasso et ul. 4,255,431 A 3/1981 Jungg,ren et al. 4,337,257 A 6/1982 Junggren et …States Patent and Trademark Office (the “PTO”) issued U.S. Patent No. 6,699,885 (the “‘885 Patent”), entitled…United States Patent (10) Patent No.: US 6,489,346 Bl Phillips - (45) Date of Patent: *Dec. 3, 2002 External link to document
2008-02-06 14 Letter ,882 (the “‘882 patent”). A fifth patent, U.S. Patent No. 5,840,737 (the “‘737 patent”) is listed in …the “‘885 patent’). Plaintiffs assert that the ‘988 patent, the ‘346 patent and the ‘885 patent are owned… infringed the ‘346 patent, the ‘885 patent, the ‘882 patent, and the ‘988 patent; 2. …infringing the ‘346 patent, the ‘885 patent, the ‘882 patent, and the ‘988 patent; and 5. … United States Patent Nos. 6,645,988 (the “‘988 patent”); 6,489,346 (the “‘346 patent”); and 6,699,885 External link to document
2008-02-22 16 Motion to Dismiss/Lack of Subject Jurisdiction Inc. (“Par”) with respect to U.S. Patent 5,840,737 (the “‘737 patent”), or in the alternative, stay the…contain any mention of United States Patent No. 5,840,737 (“the ‘737 patent”). See Comp. ¶ 12 (not listing…four patents: United States Patent Nos. 6,699,885 (“the ‘885 patent”); 6,489,346 (“the ‘346 patent”); …6,645,988 (“the ‘988 patent”); and 6,780,882 (“the ‘882 patent”) (collectively the “Patents-in-Suit”). The …and ‘882 patents. Plaintiff, however, did not assert the ‘737 patent. Instead, the ‘737 patent was placed External link to document
2010-04-14 187 included in the patents in suit. Two such references are United States Patent No. 5,093,132 (hereinafter,…‘882 Patent: Claims 11, 12, 15, 27 ‘885 Patent: Claims 2, 9, 11, 15, 16, 17, 18, 41 ‘988 Patent: Claim…‘772 Patent: All claims (see § III.A.vi) ‘885 Patent: AII claims (see § III.A.vii) 1 ‘988 Patent: Claim…and 81 of the ‘346 Patent, claim 29 of the ‘988 Patent, and claim 2 of the ‘772 Patent Those claims read…and 81 of the ‘346 Patent, claim 29 of the ‘988 Patent, and claim 2 of the ‘772 Patent cannot claim priority External link to document
2008-03-07 19 Answering Brief in Opposition . . . Crit. Care Med., 18:1092-1095. 4,255,431 3/1981 Junggren et al 424/263… Original Patent Number 5,840,737 Commissioner for Patents … I* I Utility Patent | | Design Patent | | …attached^herelo. Patent Number j Date of Patent Issued 1 ^… is described and claimed in saio patent, for which a reissue patent is sought on the invention entitled External link to document
2013-03-18 210 P129) (1985) (“Lamers”); U.S. Patent No. 5,093,132 (“Makino”); U.S. Patent No. 5,294,439 (“Yamasaka”). …invalidity of U.S. Patent Nos. 7,399,772 (the ‘772 patent) and 6,780,882 (the ‘882 patent) is not at issue…asserted claims of the '772 patent and claims 11 and 15 of the '882 patent would have been obvious.”… asserted five patents during the course of this litigation, only two of these patents remain in the litigation… invalidity determination: U.S. Patent No. 5,840,737 (“the ‘737 patent”); Pilbrant et al. , “Development External link to document
2007-09-14 3 Patent/Trademark Report to Commissioner Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,699,85 B2; 6,489,346 B1; 6,645,988…Curators of the University of Missouri 2 6,489,346 B1 12/3/02 …Pharmaceutical, Inc. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Dow
Colorcon
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.